Introduction {#Sec1}
============

Colorectal carcinoma (CRC) is the third most common malignancy worldwide \[[@CR1]\]. A rising incidence of colorectal carcinoma has been noted in recent years, high percentage of which was found to be right sided \[[@CR2]\]. There are different pathways of colorectal carcinogenesis including chromosomal instability, microsatellite instability (MSI) and CpG island methylation with overlap between these pathways. Chromosomal instability occurs in about 85% of patients with sporadic CRC and familial adenomatous polyposis and is characterized by aneuploidy, chromosomal rearrangements and accumulations of mutations in oncogenes and tumor suppressor genes \[[@CR3]\]. On the other hand, CRC secondary to MSI are because of one of the three possible pathways; germline mutations, sporadic mutations and epigenetic silencing \[[@CR4], [@CR5]\]. Germline mutations are associated with Hereditary Non-Polyposis Colon Cancer/Lynch syndrome \[[@CR6]\]. The two major pathways of colorectal carcinogenesis are associated with distinct clinicopathologic features. Chromosomal instability pathway CRC are associated with left side (distal) location, older age and pre-existing polyps while MSI pathway CRC are associated with right side (proximal) location and younger age \[[@CR4]\]. Studies have shown that MSI associated CRC have specific histologic features. MSI-H tumors are more likely to be multiple, to show polypoid growth pattern, exhibit sharply circumscribed and pushing margins and marked necrosis. Furthermore, MSI-H tumors are more likely to show mucinous or signet ring features as well as microglandular differentiation \[[@CR7], [@CR8]\]. Prognosis as well as management strategies differ in these two groups of CRC; therefore immunohistochemical and molecular testing are now routinely recommended for those patients meeting the clinical and histologic criteria \[[@CR9]--[@CR11]\]. Unfortunately in this part of the world these molecular markers are not routinely performed due to limited resources. On the other hand, surrogate clinico-pathologic features are also not widely studied. Therefore we aimed to evaluate clinicopathologic features of CRC in our population so that protocols could be developed to stratify patients requiring further biomarkers in order to be characterized into one of these two groups. Furthermore, histological features which predict higher T and N stage were also evaluated.

Main text {#Sec2}
=========

Patients and methods {#Sec3}
--------------------

Total 100 patients with CRC were included in the study that underwent primary colonic resection at Liaquat national hospital during 2013 till 2015. Patients with distant metastasis or those that received pre-operative chemo-radiation were excluded from the study. An approval from institutional ethical review committee was taken antecedent to conducting the study. Informed written content was taken from all patients at the time of surgery. After resection, specimens were sent to histopathology laboratory. After gross examination, sections were stained by hematoxylin and eosin method. Cases were examined by two senior histopathologists with more than 5 years of reporting gastrointestinal pathology. Tumor typing and grading was done according to WHO guidelines. Various histologic features were determined according to College of American pathologist guidelines using following criteria.

### Mucinous histology {#Sec4}

Extracellular mucin accumulation bounded either by neoplastic epithelium or stroma. Tumors were subgrouped as mucinous histology being absent, \< 10, 10--50 and \> 50% of tumor area involved \[[@CR12]\].

### Signet ring cells {#Sec5}

Presence of tumor cells with intracytoplasmic mucin and peripherally displaced cresent shaped nucleus, whether present within extracellular mucin pools or infiltrating stroma.

### Medullary differentiation {#Sec6}

Sheets, trabeculae or nests of small to medium sized tumor cells exhibiting syncytial pattern, frequent mitosis and abundant stromal lymphocytic infiltration.

### Necrosis {#Sec7}

Presence of dirty necrosis; further sub-grouped into focal and widespread.

### Peri-tumoral lymhocytic response {#Sec8}

Pronounced lymphoid reaction to tumor composed of lymphoid follicles with germinal centers at tumor edges, not associated with either mucosa or pre-existing lymph node. Two or more large lymphoid aggregates in a section were required for the presence of this feature \[[@CR13]\].

### Intratumoral lymphocytic infiltrate {#Sec9}

The presence of small round lymphocytes within neoplastic epithelial cells. This category was subgrouped into mild to moderate (up to 3 intra-epithelial lymphocytes/HPF) and marked (\> 3/HPF).

T and N stage was evaluated according to AJCC guidelines as follows,

**Primary tumor (T)** TX:Primary tumor cannot be assessedT0:No evidence of primary tumorTis:Carcinoma in situ: intraepithelial or invasion of lamina propriaT1:Tumor invades submucosaT2:Tumor invades muscularis propriaT3:Tumor invades through the muscularis propria into pericolorectal tissuesT4a:Tumor penetrates to the surface of the visceral peritoneumT4b:Tumor directly invades or is adherent to other organs or structures

**Regional lymph nodes (N)** NX:Regional lymph nodes cannot be assessedN0:No regional lymph node metastasisN1:Metastasis in 1--3 regional lymph nodesN1a:Metastasis in one regional lymph nodeN1b:Metastasis in 2--3 regional lymph nodesN1c:Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasisN2:Metastasis in 4 or more regional lymph nodesN2a:Metastasis in 4--6 regional lymph nodesN2b:Metastasis in 7 or more regional lymph nodes

Statistical analysis {#Sec10}
--------------------

Statistical package for social sciences (SPSS 21) was used for data compilation and analysis. Median and standard deviation were calculated for quantitative variables. Frequency and percentage were calculated for qualitative variables. Chi square was applied to determine association. *P* value ≤ 0.05 was considered significant.

Results {#Sec11}
-------

### Descriptive statistics {#Sec12}

Median age at diagnosis was 54.5 (19--85) years with a male to female ratio of 1:1. 70% cases were left sided (sigmoid and rectum). 79% cases were of conventional adenocarcinoma histology while 13% cases were of mucinous carcinoma and 74% cases were moderately differentiated. Most of the cases were at T3 stage (81%) while 27 and 68% of cases revealed lymphovascular invasion and nodal metastasis respectively. Among tumor characteristics 32 and 16% of tumors showed mucinous and signet ring features and medullary features were noted in two cases. Pre-existing polyp was seen in 10% of cases. Necrosis was present in most cases (94%). Marked host response i.e. intra-tumoral and peri-tumoral lymphocytic response was noted in 18 and 15% cases respectively (Table [1](#Tab1){ref-type="table"}).Table 1Clinicopathological and prognostic features of colorectal carcinoma in studied populationVariablen (frequency)Age (years) Median54.5 (19--85) \< 5037 (37%) \> 5063 (63%)Gender Male51 (51%) Female49 (49%)Laterality Right30 (30%) Left70 (70%)Lymphovascular invasion Present27 (27%) Absent73 (73%)T stage T11 (1%) T27 (7%) T381 (81%) T411 (11%)N stage N032 (32%) N130 (30%) N2a19 (19%) N2b19 (19%)Tumor grade Well differentiated3 (3%) Moderately differentiated74 (74%) Poorly differentiated23 (23%)Tumor type Adenoarcinoma, NOS79 (79%) Mucinous13 (13%) Medullary2 (2%) Signet ring5 (5%)Perinodal spread Present47 (47%) Absent53 (53%)Mucinous histology (%) Absent68 (68%) \< 1012 (12%) 10--507 (7%) \> 5013 (13%)Signet ring differentiation Present16 (16%) Absent84 (84%)Medullary differentiation Present2 (2%) Absent98 (98%)Necrosis Absent6 (6%) Focal70 (70%) Widespread24 (24%)Tumor infiltrating lymphocytes None57 (57%) Mild to moderate25 (25%) Marked18 (18%)Peri-tumoral lymphocytic response None67 (67%) Mild to moderate18 (18%) Marked15 (15%)Pre-existing polyp Present10 (10%) Absent90 (90%)

### Association of clinicopathological and prognostic parameters with T stage and N stage {#Sec13}

Association of various clinical and histologic features with prognostic parameters i.e. T and N stage was evaluated. Significant association of tumor features was noted with T and N stage. Poorly differentiated tumors were found to be associated with higher T and N stage. Mucinous and signet ring tumors were associated with a higher N stage. Lymphovascular invasion was found to be associated with nodal metastasis; and perinodal spread with higher T stage. Pre-existing polyp was associated with lower T and N stage. Similarly marked intra-tumoral response was negatively associated with both T and N stage (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}).Table 2Association of clinicopathological and prognostic parameters of colorectal carcinoma with T stageVariableT stageP valueT 1T2T3T4Age (years) \< 50023140.84 \> 5015507Gender Male024630.111 Female15358Laterality Right022350.62 Left15586Lymphovascular invasion Present002430.356 Absent17578Grade Well differentiated0210\< 0.001\* Moderately differentiated15655 Poorly differentiated00156Tumor type Adenocarcinoma, NOS176480.65 Mucinous carcinoma00121 Medullary carcinoma0020 Signet ring cell carcinoma0032Perinodal spread Present004070.037\* Absent17414Mucinous histology (%) Absent165470.778 \< 100093 10--500070 \> 5001111Signet ring differentiation Present011320.97 Absent16689Medullary differentiation Present00100.971 Absent178011Necrosis Absent00420.228 Focal06561 Widespread11218Tumor infiltrating lymphocytes None035050.047\* Mild-moderate10194 Marked04122Peri-tumoral lymphocytes None075370.166 Mild-moderate10143 Marked00141Pre-existing polyp Present12700.004\* Absent057411Chi square test applied\* P-value is significant Table 3Association of clinicopathological and prognostic parameters of colorectal carcinoma with N stageVariableN stageP valueN0N1N2aN2bAge (years) \< 501089100.19 \> 502222109Gender Male181310100.777 Female141799Laterality Right611580.26 Left26191411Lymphovascular invasion Present08910\< 0.001\* Absent3222109Grade Well differentiated3000\< 0.001\* Moderately differentiated2726167 Poorly differentiated24312Tumor type Adenocarcinoma, NOS29271680.006\* Mucinous carcinoma2227 Medullary carcinoma1001 Signet ring cell carcinoma0113Perinodal spread Present0131519\< 0.001\* Absent321740Mucinous histology (%) Absent26201570.006\* \< 102622 10--503004 \> 501426Signet ring differentiation Present15280.003\* Absent31251711Medullary differentiation Present10000.543 Absent31301919Necrosis Absent12300.097 Focal22201018 Widespread9861Tumor infiltrating lymphocytes None141513160.019\* Mild-moderate7953 Marked11610Peri-tumoral lymphocytes None212412100.639 Mild-moderate6345 Marked5334Pre-existing polyp Present72100.047\* Absent25281819Chi square test applied\* P-value is significant

Discussion {#Sec14}
----------

In the current study we reported detailed histopathologic features of colorectal carcinoma in Pakistani patients and features which are associated with higher T-stage and nodal metastasis. Pathologic examination of surgically resected specimens is a key factor influencing further management and includes histologic type, status of margins, pathologic staging and determining various prognostic parameters like lymphovascular invasion, perineural invasion and features of MSI. We found a significantly higher proportion of CRC at higher T-stage (T3/T4) i.e. 92%; which contrasts to early detection of CRC in many regions of the world. This may be due to lack of screening colonoscopy, delayed patient presentation or underlying genetic status of the tumors.

A significant proportion of tumors in our study showed mucinous differentiation i.e. 32% out of which 13% showed more than 50% mucinous component and thus classified as mucinous carcinoma. Mucinous carcinoma usually behaves in a more aggressive fashion compared to conventional adenocarcinoma. On the other hand mucinous differentiation when associated with MSI behaves in a less aggressive way \[[@CR14], [@CR15]\]. Mucinous differentiation in our study was associated with a higher frequency of nodal metastasis. Further studies are needed to establish its association with MSI.

Tumor infiltrating lymphocytes (TIL) and peri-tumoral lymphocytic response are markers of MSI and represents activated T-cell cytotoxic immune response in CRC \[[@CR16]\]. TIL have been found to be independently associated with improved survival in CRC after curative surgery \[[@CR17]\]. 18% of our cases were found to have marked TIL and TIL in our study was found to be associated with lower T and N stage. Moreover, only 10% of cases showed pre-existing polyp which is a marker of chromosomal instability pathway. These findings necessitate the testing of MSI status in CRC cases in our population should be evaluated, especially those tumors which show TIL and mucinous differentiation.

Among other prognostic markers of CRC; tumor grade, poor differentiation and lymphovascular invasion were found to be associated with higher risk of nodal metastasis \[[@CR18]--[@CR20]\]. Our findings are concordant with the literature. We found that higher tumor grade to be significantly associated with higher T-stage. Similarly, tumor grade and lymphovascular invasion were also found to be significantly associated with advanced N-stage.

Limitations {#Sec15}
===========

The main limitation of this study was molecular testing was not done and follow-up of patients was not available. However, the data revealed major clinical implications; we found a high proportion of our cases to present at advanced T-stage. Tumor grade and lymphovascular invasion were found to be associated with higher N-stage while tumor infiltrating lymphocytes was associated with lower T and N-stage. Moreover, a high frequency of mucinous differentiation and TIL may be linked to MSI in our cases of CRC; therefore we suggest that MSI status in CRC should be evaluated in our setup.
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